Graft Versus Host Disease
Showing 26 - 50 of 178
GVHD, Allogeneic Hematopoietic Cell Transplant Recipient Trial in Palo Alto (Regulatory T Cells)
Completed
- Graft Versus Host Disease
- Allogeneic Hematopoietic Cell Transplant Recipient
- Regulatory T Cells
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 20, 2021
Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With
Active, not recruiting
- Cutaneous T Cell Lymphoma
- Graft Versus Host Disease
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Aug 31, 2021
GVHD Trial in Stanford (donor regulatory T lymphocytes, laboratory biomarker analysis)
Suspended
- Graft Versus Host Disease
- donor regulatory T lymphocytes
- laboratory biomarker analysis
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Aug 18, 2021
GVHD, Hematopoietic Cell Transplantation Recipient Trial in New Brunswick (Dietary Intervention, Laboratory Biomarker Analysis)
Terminated
- Graft Versus Host Disease
- Hematopoietic Cell Transplantation Recipient
- Dietary Intervention
- Laboratory Biomarker Analysis
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)
Active, not recruiting
- Sickle Cell Disease
- Graft Versus Host Disease
- Diphenhydramine
- +15 more
-
Washington, District of Columbia
- +6 more
Aug 4, 2021
GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)
Completed
- Graft Versus Host Disease
- GVHD
- Panobinostat
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021
Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)
Terminated
- Leukemia
- +2 more
- cyclosporine
- cyclosporine and methotrexate
-
Los Angeles, California
- +12 more
May 3, 2021
GVHD Trial in New Brunswick (Lactobacillus rhamnosus GG, laboratory biomarker analysis was not performed because of no
Completed
- Graft Versus Host Disease
- Lactobacillus rhamnosus GG
- laboratory biomarker analysis was not performed because of no differences in the clinical outcomes
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 23, 2021
GVHD Trial in Hangzhou (Ruxolitinib+Calcineurin +Methotrexate, Calcineurin +Methotrexate+Mycophenolate mofetil)
Recruiting
- Graft Versus Host Disease
- Ruxolitinib+Calcineurin +Methotrexate
- Calcineurin +Methotrexate+Mycophenolate mofetil
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Apr 8, 2021
GVHD, Acute GVHD, Chronic GVHD Trial in Atlanta (Autologous mesenchymal stromal cells (MSCs))
Completed
- Graft Versus Host Disease
- +2 more
- Autologous mesenchymal stromal cells (MSCs)
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Mar 2, 2021
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
GVHD Trial in Augusta (GLASSIA, methylprednisolone or equivalent steroid, Albumin)
Terminated
- Graft Versus Host Disease
- GLASSIA
- +2 more
-
Augusta, GeorgiaGeorgia Cancer Center
Dec 22, 2020
Dynamic of Immunocompetent Populations in Patients Treated With
Recruiting
- Graft Versus Host Disease
- Extracorporeal Photopheresis
- Blood samples
- skin biopsy
-
Lille, FranceHôpital Claude Huriez, CHU
Nov 18, 2020
Poor Graft Function, Stem Cell Transplantation, GVHD Trial in Beijing (infusion of G-CSF mobilized peripheral harvest)
Completed
- Poor Graft Function
- +2 more
- infusion of G-CSF mobilized peripheral harvest
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Sep 23, 2020
Bronchiolitis Obliterans, Constructive Bronchiolitis, GVHD Trial run by the NHLBI (Cyclosporine Inhalation Solution (CIS))
Completed
- Bronchiolitis Obliterans
- +5 more
- Cyclosporine Inhalation Solution (CIS)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 31, 2020
GVHD, Leukemia, MDS Trial in New Haven, Seattle (drug, radiation, other, procedure, biological)
Terminated
- Graft Versus Host Disease
- +2 more
- Fludarabine Phosphate
- +7 more
-
New Haven, Connecticut
- +1 more
Aug 10, 2020
GVHD, Leukemia Trial (biological, drug, procedure)
Withdrawn
- Graft Versus Host Disease
- Leukemia
- therapeutic allogeneic lymphocytes
- +7 more
- (no location specified)
Jul 29, 2020
GVHD Trial in Boston (Interleukin-2)
Completed
- Graft Versus Host Disease
-
Boston, MassachusettsDana-Farber Cancer Institute
Jun 22, 2020
GVHD Trial in Sacramento (Bortezomib)
Completed
- Graft Versus Host Disease
-
Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
May 26, 2020
GVHD Trial in Boston (Natalizumab, Methylprednisolone)
Completed
- Graft Versus Host Disease
-
Boston, Massachusetts
- +1 more
Apr 7, 2020
Identification of Novel Targetable Kinases in SR-a GvHD
Completed
- Graft Versus Host Disease
- (no location specified)
Apr 8, 2020
GVHD Trial in Freiburg (Teduglutide)
Completed
- Graft Versus Host Disease
-
Freiburg, Baden Württemberg, GermanyMedical Center University of Freiburg
Feb 26, 2020
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Salt Lake City, Seattle, Torino
Completed
- Acute Lymphoblastic Leukemia
- +9 more
- Cyclosporine
- +3 more
-
Salt Lake City, Utah
- +4 more
Jan 15, 2020
GVHD Trial (cryopreservation)
Unknown status
- Graft Versus Host Disease
- cryopreservation
- (no location specified)
Jan 23, 2020
GVHD, Leukemia, Lymphoma Trial in Minneapolis (anti-thymocyte globulin, cyclophosphamide, cyclosporine)
Withdrawn
- Graft Versus Host Disease
- +2 more
- anti-thymocyte globulin
- +7 more
-
Minneapolis, MinnesotaUniversity of Minnesota Cancer Center
Dec 31, 2019